Clotrimazole is an imidazole derivative and an antifungal compound and a CYP (cytochrome P450) inhibitor. Clotrimazole has been shown to block the intermediate-conductance, IK1 channels (Ca2+ activated K+ channels), in cells such as erythrocytes. In vitro studies of various yeast strains have demonstrated susceptibility to clotrimazole. Clotrimazole is an activator of MB67 and an inhibitor of CYP3A4 and CYP51A1.
This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.
Applications
Clotrimazole is an imidazole derivative and an antifungal compound and a CYP (cytochrome P450) inhibitor. Clotrimazole has been shown to block the intermediate-conductance, IK1 channels (Ca2+ activated K+ channels), in cells such as erythrocytes. In vitro studies of various yeast strains have demonstrated susceptibility to clotrimazole. Clotrimazole is an activator of MB67 and an inhibitor of CYP3A4 and CYP51A1.
Solubility
Soluble in chloroform, DMSO, DMF and alcohols
Notes
Store at room temperature. Incompatible with oxidizing agents.
RUO – Research Use Only
General References:
- E.B Souto.; b, S.A Wissing.; C.M Barbosa.; R.H Müller. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery.Int. J. Pharm. 2004, 278 (1),71-77 .
- Jack D. Sobel.; Doris Brooker.; Gary E. Stein.; Jessica L. Thomason.; Daniel P. Wermeling.; Blake Bradley.; Louis Weinstein. Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis.American Journal of Obstetrics and Gynecology. 1995, 172 (4),1263-1268 .